Saturday 17 October 2026 Export ATR’s income statement to Excel — free account

AptarGroup, Inc.

ATR Healthcare Medical Instruments & Supplies

AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024. In the quarter to June 2026, revenue grew 6.26%, EPS fell 18.3%, free cash flow fell 23.1% and total debt rose 66.4%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten.

124.51 0.25 +0.20%

Follow ATR

Alert me

Market cap: $7.9B
P/E: 22.2×
Fwd P/E: 21.0×
Dividend yield: 1.54%
F-score: 5/9
Altman Z: 3.78
Beneish M: −2.48
Dividend safety: 92/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 7.82

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	1	—	2	—	—	2	2	—	4	1	—

Insider Ownership 1.95%

Capital & Financial Ratios $m

Market Cap 7,900.00

Revenue 3,933.24

Net Income 362.88

Free Cash Flow 314.58

Net Debt 1,170.39

Current Ratio 1.61

Debt/Equity 0.52

P/E ratio 22.23

Fwd P/E 21.00

P/S ratio 2.01

P/B ratio 2.99

Past 5Y EPS Growth 12.91%

This Y EPS Growth (4.09%)

Next Y EPS Growth 13.13%

Next Y revenue growth 5.26%

Next 5Y EPS Growth 6.49%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 7.63%

10-year low 10-year high

P/S against its own 10 years 8.66%

10-year low 10-year high

P/B against its own 10 years 4.02%

10-year low 10-year high

EV/Sales against its own 10 years 14.63%

10-year low 10-year high

EV/FCF against its own 10 years 19.79%

10-year low 10-year high

Dividends

Payout Ratio 0.35

Annual Dividend Rate 1.92

Annual Dividend Yield 1.54%

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	1.94	0.48 0.48 0.48
2025	1.83	0.45 0.45 0.45 0.48
2024	1.72	0.41 0.41 0.45 0.45
2023	1.58	0.38 0.38 0.41 0.41
2022	1.52	0.38 0.38 0.38 0.38
2021	1.50	0.36 0.38 0.38 0.38
2020	1.44	0.36 0.36 0.36 0.36
2019	1.42	0.34 0.36 0.36 0.36
2018	1.32	0.32 0.32 0.34 0.34
2017	1.28	0.32 0.32 0.32 0.32
2016	1.22	0.30 0.30 0.30 0.32

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	224	226	410	197
Receivables	678	658	804	898
Inventory	513	462	538	580
Other	—	—	—	—
	1,549	1,478	1,894	1,835

	2023	2024	2025	Q'26
Payables	793	730	823	887
ST’ Debt	376	338	344	249
Other	—	—	—	—
	1,251	1,068	1,166	1,137

Compound Annual Growth %

	10y	5y	3y
Sales	5.01%	5.22%	4.37%
Cash Flow	5.82%	(0.01%)	6.00%
Earnings	7.02%	12.91%	17.96%
Book Value	8.86%	7.73%	9.10%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	983	1,027	—	—	—
’25	887	966	961	963	3,777
’24	915	910	909	848	3,583
’23	860	896	893	838	3,487
’22	845	845	837	796	3,322
’21	777	811	825	814	3,227
’20	722	699	759	749	2,929

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	119	103	—	—	—
’25	83	126	178	184	570
’24	92	144	229	178	643
’23	98	84	173	220	575
’22	92	85	130	172	479
’21	72	103	84	104	363
’20	85	143	154	189	570

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	54	47	—	—	—
’25	23	61	116	98	298
’24	17	76	149	108	351
’23	20	9	97	135	262
’22	19	10	46	87	163
’21	9	34	4	13	61
’20	20	86	102	116	323

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	1.12	1.36	—	—	—
’25	1.17	1.67	1.92	1.13	5.89
’24	1.23	1.34	1.48	1.49	5.53
’23	0.82	1.24	1.26	0.93	4.25
’22	0.93	0.95	0.81	0.89	3.59
’21	1.24	0.81	0.70	0.85	3.61
’20	0.84	0.63	0.95	0.79	3.21

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	66.33	71.44	79.97	88.26	79.84	112.37	90.23	107.89	122.29	103.23	Analyst estimates 2026–2028 Powerpack
	High	81.50	90.79	112.31	126.20	137.36	158.97	124.14	133.79	178.03	164.28
People
People	Employees	12,700	13,200	14,100	14,000	13,000	13,000	13,500	13,800	13,500	14,000
	Revenue/emp, $m	0.18	0.19	0.20	0.20	0.23	0.25	0.25	0.25	0.27	0.27
Income, $m
Income, $m	Revenue	2,331	2,469	2,765	2,860	2,929	3,227	3,322	3,487	3,583	3,777
	Gross margin, %	35.81	35.08	34.43	36.41	37.09	35.84	35.03	36.23	37.83	37.19
	EBT	280	295	266	342	301	322	335	375	470	491
	EBT margin, %	12.03	11.94	9.62	11.96	10.28	9.97	10.07	10.75	13.11	13.01
	Net income	206	220	195	242	214	244	240	284	374	392
	Depreciation	155	153	172	195	220	235	234	249	264	287
Per share, $
Per share, $	Revenue	37.11	39.55	44.28	44.98	45.47	49.15	50.80	53.15	54.01	57.46
	Earnings	3.27	3.52	3.12	3.81	3.32	3.72	3.66	4.34	5.65	5.97
	Cash flow	5.18	5.20	5.02	8.09	8.85	5.54	7.32	8.77	9.70	8.67
	Capex	(2.07)	(2.48)	(3.32)	(3.82)	(3.83)	(4.61)	(4.82)	(4.77)	(4.41)	(4.14)
	Free cash flow	3.11	2.73	1.70	4.27	5.02	0.93	2.49	4.00	5.29	4.53
	Book value	18.70	21.01	22.79	24.73	28.73	30.22	31.62	35.38	37.48	40.86
	Shares, m	63	62	62	64	64	66	65	66	66	66
Valuation, ×
Valuation, ×	P/E	22.33	24.65	30.15	30.35	41.23	32.84	30.21	28.31	27.81	20.43
	P/S	1.97	2.20	2.12	2.57	3.01	2.49	2.17	2.31	2.91	2.12
	P/B	3.91	4.14	4.13	4.68	4.76	4.05	3.49	3.47	4.19	2.99
	EV/Sales	2.10	2.42	2.46	2.89	3.29	2.78	2.48	2.55	3.13	2.41
	EV/FCF	25.05	35.63	64.01	30.40	29.81	164.11	51.31	33.93	31.99	30.50
Cash, $m
Cash, $m	Operating cash flow	325	325	314	514	570	363	479	575	643	570
	Capex	(130)	(155)	(207)	(243)	(247)	(303)	(316)	(313)	(293)	(272)
	Free cash flow	196	170	106	272	323	61	163	262	351	298
Balance, $m
Balance, $m	Working capital	727	1,142	642	608	589	376	513	298	410	727
	Total debt	777	1,253	1,189	1,151	1,121	1,049	1,172	1,058	1,026	1,483
	Net debt	311	540	927	909	820	926	1,030	834	800	1,073
	Shareholders’ equity	1,174	1,312	1,423	1,572	1,851	1,985	2,068	2,321	2,486	2,686
Returns, %
Returns, %	ROA	8.15	7.66	5.98	6.98	5.67	6.00	5.74	6.57	8.43	8.11
	ROIC	13.20	10.91	7.61	9.36	7.94	7.46	7.65	8.00	9.44	8.33
	ROE	17.69	17.70	14.24	16.17	12.51	12.73	11.81	12.96	15.58	15.19

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
RGEN Repligen Corporation	$11.7B	234×	112×	+11.93% (above 0%: growing)	−65.38% (below 0%: shrinking)	+27.10% (above 0%: growing)	53.91%	6.85%	Compare
COO The Cooper Companies, Inc.	$10.9B	19.8×	28.7×	+0.56% (above 0%: growing)	+357.14% (above 0%: growing)	+65.96% (above 0%: growing)	66.77%	20.82%	Compare
AVTR Avantor, Inc.	$10.9B	— (loss-making)	25.5×	+0.53% (above 0%: growing)	−33.33% (below 0%: shrinking)	+12.66% (above 0%: growing)	31.73%	7.20%	Compare
ALGN Align Technology, Inc.	$10.6B	25.6×	20.7×	+4.32% (above 0%: growing)	−12.21% (below 0%: shrinking)	+85.77% (above 0%: growing)	71.71%	14.58%	Compare
ATR AptarGroup, Inc.	$7.9B	22.2×	21.0×	+6.26% (above 0%: growing)	−18.34% (below 0%: shrinking)	−23.07% (below 0%: shrinking)	35.61%	12.34%
BLCO Bausch + Lomb Corporation	$6.0B	— (loss-making)	— (loss-making)	+9.08% (above 0%: growing)	n/m	+251.85% (above 0%: growing)	62.20%	5.95%	Compare
TFX Teleflex Incorporated	$5.4B	— (loss-making)	45.3×	+28.88% (above 0%: growing)	−17.33% (below 0%: shrinking)	+220.14% (above 0%: growing)	58.16%	12.77%	Compare
MMSI Merit Medical Systems, Inc.	$5.4B	36.4×	23.4×	+9.51% (above 0%: growing)	+18.18% (above 0%: growing)	−25.66% (below 0%: shrinking)	51.37%	14.42%	Compare
STVN Stevanato Group S.p.A.	$5.3B	33.8×	27.5×	+10.46% (above 0%: growing)	−25.00% (below 0%: shrinking)	−167.02% (below 0%: shrinking)	28.75%	12.93%	Compare
Median of peers	$8.3B	33.8×	27.5×	+9.30%	−17.33%	+46.53%	56.04%	12.85%

All 55 Medical Instruments & Supplies stocks →

AptarGroup, Inc. (ATR) key facts

Strength: AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.
Strength: Net income was $392.5 million, or $5.97 per share (basic), a net margin of 10.4%.
AptarGroup, Inc. (ATR) is a Medical Instruments & Supplies company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, ATR traded at $124.51, a market capitalization of $7.9 billion.
At that price the stock trades at 22.2× trailing-twelve-month earnings and 2.0× sales; its P/E is higher than 8% of its own readings over the past ten years.
AptarGroup, Inc. pays an annual dividend of $1.92 per share, a yield of 1.54%, with a payout ratio of 34.7%.
Return on equity was 15.2% and debt-to-equity 0.52.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 3.78 (safe zone) for fiscal 2025.